Tower Research Capital (TRC)’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-8,488
| Closed | -$74K | – | 4597 |
|
|
2018
Q2 | $74K | Buy |
8,488
+5,692
| +204% | +$49.6K | ﹤0.01% | 1625 |
|
|
2018
Q1 | $28K | Sell |
2,796
-329
| -11% | -$3.3K | ﹤0.01% | 2008 |
|
|
2017
Q4 | $15K | Buy |
3,125
+151
| +5% | +$725 | ﹤0.01% | 2301 |
|
|
2017
Q3 | $14K | Buy |
2,974
+2,414
| +431% | +$11.4K | ﹤0.01% | 2939 |
|
|
2017
Q2 | $3K | Buy |
560
+396
| +241% | +$2.12K | ﹤0.01% | 2293 |
|
|
2017
Q1 | $1K | Buy |
+164
| New | +$1K | ﹤0.01% | 2930 |
|
|
2016
Q3 | – | Sell |
-931
| Closed | -$7K | – | 5017 |
|
|
2016
Q2 | $7K | Sell |
931
-3,051
| -77% | -$22.9K | ﹤0.01% | 3208 |
|
|
2016
Q1 | $27K | Buy |
3,982
+1,823
| +84% | +$12.4K | ﹤0.01% | 1151 |
|
|
2015
Q4 | $22K | Buy |
2,159
+2,086
| +2,858% | +$21.3K | ﹤0.01% | 1226 |
|
|
2015
Q3 | $1K | Sell |
73
-958
| -93% | -$13.1K | ﹤0.01% | 3781 |
|
|
2015
Q2 | $9K | Buy |
1,031
+931
| +931% | +$8.13K | ﹤0.01% | 2847 |
|
|
2015
Q1 | $1K | Sell |
100
-1,333
| -93% | -$13.3K | ﹤0.01% | 4240 |
|
|
2014
Q4 | $8K | Buy |
+1,433
| New | +$8K | ﹤0.01% | 2389 |
|
|
2014
Q2 | – | Sell |
-1,436
| Closed | -$10K | – | 5023 |
|
|
2014
Q1 | $10K | Buy |
1,436
+1,318
| +1,117% | +$9.18K | ﹤0.01% | 2644 |
|
|
2013
Q4 | $1K | Sell |
118
-898
| -88% | -$7.61K | ﹤0.01% | 4310 |
|
|
2013
Q3 | $7K | Buy |
+1,016
| New | +$7K | ﹤0.01% | 3491 |
|